Yes, TACT is following XBB.2.3 and its sub-variants very closely. For example, XBB.2.3 (Nextclade) + N:T247I has a 230% early estimated advantage. Only one sequenced in NY so far. The mutations in the body of the virus suggest it is looking for ways to better evade T-cells, allowing more replication and infiltration into the lower respiratory tract. It may be more likely to cause multi-organ damage and to persist throughout the body, including the brain. The increasing rate of mutations in the body of the virus is very concerning.
Hi! Providing any additional support is really needed and appreciated. Keeping up with the latest data is extremely time consuming. Just keep in mind that many of the posts made available on substack aren't available on patreon yet and substack is where new updates are posted first. This is the link. patreon.com/TACTNowinfo Thanks for reading and for your support.
Hi TACT...
Singapore looks quite interesting now. It appears that Arcturus is rolling over, BUT Acrux (XBB.2.3) is in the ascendency. Acrux is a mean 'Effer.
Yes, TACT is following XBB.2.3 and its sub-variants very closely. For example, XBB.2.3 (Nextclade) + N:T247I has a 230% early estimated advantage. Only one sequenced in NY so far. The mutations in the body of the virus suggest it is looking for ways to better evade T-cells, allowing more replication and infiltration into the lower respiratory tract. It may be more likely to cause multi-organ damage and to persist throughout the body, including the brain. The increasing rate of mutations in the body of the virus is very concerning.
How do I search for T.A.C.T. on patreon? I have tried "T.A.C.T." and "TACT", but I get too many matches.
Hi! Providing any additional support is really needed and appreciated. Keeping up with the latest data is extremely time consuming. Just keep in mind that many of the posts made available on substack aren't available on patreon yet and substack is where new updates are posted first. This is the link. patreon.com/TACTNowinfo Thanks for reading and for your support.